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An aptamer-capped mesoporous material for the selective and sensitive detection of 
thrombin in human plasma and serum has been prepared and characterized. 
The design of stimuli-responsive nanoscopic gated systems involving biomolecules has recently 
attracted great attention. In particular some biomolecules, especially enzymes,i have been used 
as stimuli to uncap gated-scaffolds whereas others such as saccharides,ii antibodies,iii peptidesiv 
or DNA,v have been reported to act as capping agents. Capped materials have been mainly used 
in drug delivery applications. However examples of their use in sensing are by far much less 
common. vi  In the latter approach the carrier system is loaded with a dye and the capped 
mechanism is designed in a way that only a target analyte is able to trigger the delivery of the 
cargo. Among different biomolecules that could act as caps aptamers are especially attractive 
for the design of gated nanosensors for sensing applications.vii  
 On the other hand thrombin is a coagulation protein that has many effects in the coagulation 
cascade and their determination can be used to understand thrombosis and hemostasis processes. 
This protein, also known as coagulation factor II, is a serine protease that converts soluble 
fibrinogen (factor I) into insoluble strands of fibrin (factor Ia). viii , ix  The concentration of 
thrombin in blood varies considerably and can be almost absent in healthy subjects. However, 
during coagulation process, the concentration of thrombin in blood ranges from nM to low μM 
levels.x Moreover it is important to detect thrombin in blood serum for clinical and diagnostic 
applications.xi 
 Recently, various aptasensors based on electrochemistry, xii  colorimetry, xiii  fluorescence, xiv 
electrochemiluminescence, xv  and other techniques xvi  for thrombin detection have been 
developed. For instance, electrochemical aptasensors for thrombin detection based on 
nanoparticle labeling have been also described. For labeling purposes gold nanoparticles,xvii  
quantum dots xviii or carbon nanotubesxix   have been widely used. One of the most commonly 
used aptamers, in the development of thrombin aptasensors,  is the 15-mer DNA aptamer d(5-
GGTTGGTGTGGTTGG-3), also known as thrombin-binding aptamer (TBA),xx which is able to 
bind selectively onto exosite I thrombin (fibrinogen binding sites) with highly specificity versus 
other substances.xxi 
Despite the examples cited above, as far as we know, the use of TBA gated-hybrid mesoporous 
materials for the recognition of thrombin has not yet been reported. Taking these facts into 
account, in this work we present a new hybrid gated material for the fluorometric detection of 
thrombin. Based in our experience in the fields of bio-gated hybrid materials for sensing 
applicationsxxii we report herein the preparation of an aptamer-gated silica mesoporous supports 
for the selective and sensitive fluorogenic signalling of thrombin. 
Scheme 1 shows the proposed paradigm for thrombin detection using capped mesoporous 
materials. MCM-41 mesoporous nanoparticles (diameter of ca. 100 nm) were selected as 
inorganic scaffold and the pores were loaded with a fluorophore (rhodamine B). Then the 
external surface of the loaded support was functionalized with 3-aminopropyltriethoxysilane 
(APTS) (solid S1). Aminopropyl moieties are partially charged at neutral pH and should display 
electrostatic interactions with the negatively charged TBA aptamer. Addition of TBA yielded 
the final capped hybrid material S1-TBA. In particular for the preparation of the gated material 
S1-TBA, 1.5 mg of S1 were suspended in 1.5 mL of simulated human blood plasma (pH 
7.25).xxiii Then, 60 µl of TBA (28 µM) were added to 150 µl of the S1 suspension. The final S1-
TBA solid was isolated by centrifugation and washed with 300 µl of simulated human blood 



















Scheme 1. Schematic representation of the gated material S1 functionalised with 3-
aminopropiltriethoxysilane and capped with TBA aptamer in quadruplex state (S1-TBA). The 
delivery of the entrapped guest (rhodamine B) is observed in the presence of thrombin. 
 
S1 was characterized using standard procedures. X-ray pattern of S1 shows the mesoporous 
characteristic (100) peak diffraction indicating that the loading process with the dye and the 
further functionalization with APTS have not damaged the mesoporous scaffolding (see Figure 
S2). The presence in the final functionalized solids of the mesoporous structure is also clearly 
observed from the TEM analysis (see Figure S2). The N2 adsorption-desorption isotherms of the 
calcined MCM-41 nanoparticles (Figure S3) showed an adsorption step at an intermediate P/P0 
value (0.1 – 0.3). From this curve a pore volume of 0.84 cm3 g-1 was calculated by using the 
BJH model on the adsorption branch of the isotherm. The application of the BET model resulted 
in a value for the total specific surface area of 1066.8 m2 g-1. From the XRD, porosimetry and 
TEM measurements a pore diameter of 2.57 nm was determined. The N2 adsorption-desorption 
isotherm of S1 is typical of mesoporous systems with filled mesopores (see Figure S3), and a 
significant decrease in the N2 volume adsorbed and a surface area (77 m2 g-1) was observed. 
 The content of dye and APTS on solid S1 were determined by elemental analysis and 
thermogravimetric studies and amounts to 0.092 and 1.65 mmol/g solid, respectively. 
Additionally, the content of TBA in solid S1-TBA was determined through the use of aptamer 
TBA-flu (5-GGTTGGTGTGGTTGG-fluorescein-3), similar to TBA but functionalized with a 
fluorescein dye. By following the decrease in absorbance of TBA-flu in the solution after the 
capping process and monitoring the TBA-flu released during uncapping experiments (see SI for 
















































Figure 1. Release profile of rhodamine B from solid S1-TBA in absence (a) and in presence (b) 
of thrombin (2.89 µM) in simulated human blood plasma (pH 7.25).  
 
 In order to investigate the gating properties of S1-TBA, 150 µg of S1-TBA were suspended 
in 1.5 mL of simulated human blood plasma and the suspension was divided into two fractions. 
The first fraction was diluted with 286 µL of Milli-Q water, the second one was treated with 
286 µL of an aqueous solution containing 2.89 µM of thrombin. In both cases the suspensions 
were stirred for 90 minutes at 37°C and a certain time intervals fractions were taken and 
centrifuged to remove the solid. Dye delivery at a certain time was then measured via the 
fluorescence emission of the rhodamine in the solution at 572 nm (λexc 555 nm). The delivery 
kinetics profile of rhodamine B in the presence and absence of the target protein thrombin is 
displayed in Figure 1. In absence of thrombin (curve a) solid S1-TBA shows a negligible dye 
release, indicating tight pore closure. On the other hand, the delivery of the dye is induced when 
thrombin is present in the solution due to displacement of the aptamer from the nanoparticles as 
consequence of aptamer-thrombin recognition (curve b). At 60 minutes ca. 80% of the delivery 















Figure 2. Release of rhodamine B from S1-TBA as a function of the concentration of thrombin 
added (after 60 min of reaction) in simulated human blood plasma (pH 7.25). 
 
 
Following a similar procedure delivery of rhodamine B from S1-TBA as a function of the 
amount of thrombin and the results are shown in Figure 3. As it can be seen the cargo delivered 
is proportional to thrombin concentration in agreement with the uncapping protocol detailed 
above. The maximum delivery was observed at a concentration of 1700 nM of thrombin. Finally, 
a limit of detection of 2 nM (3σ) of thrombin was found.  
The use of gated materials for sensing applications has as an specialfeature to separates the 
recognition protocol (in our case the formation of TBA-protein pair) from the signalling event 
making sensing independent of the stocichiometry of the host-guest complex and sometimes 
displaying features of signal enhancement. In our particular case, at low thrombin 
concentrations (ca. 4 nM), one molecule of thrombin was able to deliver ca. 115 molecules of 
dye, which is a remarkable sign of signal amplification. 
The in vitro characterization of the nanodevice suggested that S1-TBA nanomaterial is sensitive 
to the presence of thrombin. Moreover, in order to study the possible application in the detection 
of thrombin in biological samples, S1-TBA was tested using commercially available human 
serum (from human male AB plasma). In a first step, the tolerance of the solid to human serum 
was studied, suspending 1 mg of S1-TBA in 1 mL of serum diluted with PBS (40, 20, 10 and 
5%). From these measurements a 10% serum dilution showed the best response with a limit of 
detection as low as 4 nM of thrombin (3σ; see Figure S4 and experimental details in the SI). In a 
second step, with the aim to verify the feasibility of the developed method, we prospectively 
used solid S1-TBA for the determination of thrombin in human serum. For this purpose, in a 
typical experiment, human serum samples were spiked with 75, 150 and 300 nM of thrombin, 
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respectively. Samples were diluted with PBS for a final amount of 10%, and the contents of 
human thrombin were determined with S1-TBA material using the addition standard method. 
The obtained results are shown in Table S1. Remarkable recoveries in the range of 91-120% of 














Figure 3. Fluorescence of rhodamine B released from S1-TBA suspensions (in PBS containing 
10% human serum) in the presence of thrombin (56 nM), and a mixture of OVA and BSA (56 
nM) after 15 minutes of the addition. For comparative purposes the release of rhodamine B 
from S1-TBA suspensions in PBS containing 10% human serum is also shown.  
 
 
In order to further investigate the selectivity of S1-TBA material control release experiments in 
the presence of other non-specific binding proteins (OVA and BSA) were carried out. In 
particular, PBS containing 10% of human serum was spiked with 56 nM of OVA and BSA and 
the rhodamine B released after 15 min measured. Figure 3 showed that a mixture of OVA and 
BSA was unable to induce the uncapping of the pores, observation that reinforces the selective 
thrombin-TBA interaction as the mechanism of the fluorogenic response observed. 
 In conclusion, we have prepared an aptamer-gated delivery system (S1-TBA) for the 
fluorogenic detection of thrombin. The sensing mechanism arises from the high affinity between 
an aptamer (TBA) and its target protein (thrombin). In vitro studies with S1-TBA showed a 
limit of detection of 2 nM (3σ) for thrombin. In addition the hybrid nanomaterial allowed 
accurate thrombin detection in human serum diluted with PBS also with high sensitivity (limit 
of detection of 4 nM (3σ)). The method, based in a simple competitive procedure is 
undemanding and suggested that the use of aptaners could be a suitable approach to develop 
gated nanoparticles for simple chromo-fluorogenic assays for a wide range of bio-applications.  
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Chemicals 
The chemicals tetraethylorthosilicate (TEOS), n-cetyltrimethylammonium bromide 
(CTABr), sodium hydroxide (NaOH), rhodamine B, 3-aminopropiltriethoxysilane and 
human serum – from human male AB plasma (sterile-filtered) were provided by 
Aldrich. The aptamers TBA d(5- GGTTGGTGTGGTTGG -3) and TBA-flu d(5- 
GGTTGGTGTGGTTGG-fluorescein-3) were provided by the group of Nucleic Acids 
from the Institute for Research in Biomedicine of Barcelona (IRB Barcelona). 
Analytical-grade solvents were from Scharlab (Barcelona, Spain). All reactives were 
used as received.  
General Techniques 
 XRD, TG analysis, elemental analysis, TEM microscopy, N2 adsorption-desorption and 
UV-visible spectroscopy techniques were employed to characterize the prepared 
materials. X-ray measurements were performed on a Brücher AXS D8 Advance 
diffractometer using Cu-Kα radiation. Thermo-gravimetric analysis were carried out on 
a TGA/SDTA 851e Mettler Toledo equipment, using an oxidant atmosphere (Air, 80 
mL/min) with a heating program consisting on a heating ramp of 10 °C per minute from 
393 K to 1273 K and an isothermal heating step at this temperature during 30 minutes. 
TEM images were taken with a JEOL TEM-1010 Electron microscope working at 100 
kV. N2 adsorption-desorption isotherms were recorded on a Micromeritics ASAP2010 
automated sorption analyser. The samples were degassed at 120ºC in vacuum overnight. 
The specific surfaces areas were calculated from the adsorption data in the low 
pressures range using the BET model. Pore size was determined following the BJH 
method. UV-visible spectroscopy was carried out with a Jasco V-630 Spectrometer. 
Fluorescence spectroscopy was carried out on a Jasco FP-8300 Spectrometer and UV-
visible spectroscopy was carried out with a Jasco V-630 Spectrometer.  
Buffer Solutions 
Phosphate buffered saline 1x (PBS 1x) consisting in 137 mM NaCl, 1.47 mM KH2PO4, 
7.85 mM Na2HPO4, 2.68 mM  KCl (pH:7.5) was used for controlled release 
experiences.  
Synthesis of the silica mesoporous nanoparticles support (SMPS)  
The MCM-41 mesoporous nanoparticles were synthesized by the following procedure: 
n-cetyltrimethylammoniumbromide (CTABr, 1.00 g, 2.74 mmol) was first dissolved in 
480 mL of deionized water. Then a 3.5 mL of NaOH 2.00 M in deionized water was 
added to the CTABr solution, followed by adjusting the solution temperature to 80ºC. 
TEOS (5 mL, 2.57. 10-2 mol) was then added dropwise to the surfactant solution. The 
mixture was allowed stirred for 2 h to give a white precipitate. Finally the solid product 
was centrifuged, washed with deionized water and was dried at 60ºC (MCM-41 as-
synthesized). To prepare the final porous material (MCM-41), the as-synthesized solid 
was calcined at 550 ºC using oxidant atmosphere for 5 h in order to remove the template 
phase.  
Synthesis of S1 
The amino-functionalised solid S1 was prepared following literature procedures. 500 
mg of calcined MCM-41 and 33.2 mg (0.10 mmol) of dye rhodamine B were suspended 
in 40 mL of acetonitrile inside a round-bottom flask connected to a Dean-Stark in an 
inert atmosphere. The suspension was refluxed (110 ºC) in azeotropic distillation, 
collecting 10 mL in the trap in order to remove the adsorbed water. Then, the mixture 
was stirred during 24 hours at 36ºC with the aim of achieving maximum loading in the 
pores of the MCM-41 scaffolding. Afterward an excess of 3-aminopropiltriethoxysilane 
(APTS, 0.936 mL, 4.0 mmol) was added, and the                             
suspension was stirred for 5.5 h. Finally, the pink solid (S1) was filtered off and dried at 
70 ºC for 12h.  
Synthesis and optimization of solid S1-TBA 
In order to estimate the proper amount of TBA for the preparation of S1-TBA, capping 
and release experiments in presence of different amounts of TBA were carried out. First 
of all, portions of  50 µL of a suspension of 1 mg S1/1 mL PBS were added to a 
solution containing the aptamer TBA-flu d(5- GGTTGGTGTGGTTGG -fluorescein-3)  
in concentrations of (0.02, 0.04, 0.06 and 0.08 µmol of TBA-flu g solid-1) in Milli-Q 
water, and each suspension was stirred during 30 min at 37ºC, respectively. Afterwards, 
the absorbance of TBA-flu in the solution after the capping process was measured, in 
order to estimate the content of TBA-flu retained into solid. Results are shown in Table 
S1.  
Table S1. Content of TBA added for the synthesis of S1-TBA and TBA retained during 
the process in mmol g-1 S1. 
TBA added  
(mmol g-1 S1) 
TBA retained  
(mmol g-1 S1) 
% retained 
(mmol g-1 S1) 
0.02 0.0123 61.55 
0.04 0.0164 44.25 
0.06 0.0134 22.44 
0.08 0.0027 3.43 
 
 For study the release properties of the prepared solids, some release studies were 
carried. The isolated solids were divided in two parts. To one part, a solution of 250 µL 
PBS 1x containing human α thrombin in concentrations of: 0.04, 0.06 and 0.08 µmol of 
thrombin g solid-1; to the other part 250 µL PBS 1x were added. The suspensions were 
stirred for one hour; during this period two aliquots of the suspensions were taken. 
Finally, after centrifugation of all the aliquots the fluorescence of rhodamine B emission 
at 572 nm (λex = 555nm) delivered to the solution was measured.  It was found that all 
the concentrations were able to induce an effective capping of the pores, but in terms of 
dye release the concentration of the TBA at 0.04 mmol g-1 S1, showed more dye 
delivery than the others two TBA concentrations (0.06 and 0.08 mmol g-1 S1). Results 















TBA concentration / mmol g -1 S1
 
Figure S1. Optimization of the concentration of TBA to reach an effective capping of 
the pores. The black bars represent the blanks (absence of thrombin) and the grey bars 
represent the samples in presence of thrombin 0.04, 0.06 and 0.08 µmol of thrombin g 
solid-1, respectively. All the measurements were carried out in PBS 1x (pH 7.5). 
With the aim to obtain solid S1-TBA, 50 µL of a suspension of 1 mg S1 in 1 mL PBS 
were suspended in 20 µl of a solution containing the aptamer TBA d(5- 
GGTTGGTGTGGTTGG -3)  in a concentration of 28.57 µM in Milli-Q water, and the 
suspension was stirred at 37ºC during 30 min. The final S1-TBA solid was isolated by 
centrifugation and washed with 100 µL of PBS buffer (pH 7.5) in order to remove the 
residual dye and the free aptamer TBA.  
Materials Characterization 
Solid S1 was characterized using standard procedures. Figure S2 shows powder X-ray 
patterns of the nanoparticulated MCM-41 as made support, calcined MCM-41 and the 
S1 functionalized material. The PXRD of siliceous nanoparticulated MCM-41 as-
synthesized (curve a) shows four low-angle reflections typical of a hexagonal array that 
can be indexed as (100), (110), (200), and (210) Bragg peaks. A significant 
displacement of the (100) peak in the XRD powder of the nanoparticulated MCM-41 
calcined sample is clearly appreciated in the curve b, corresponding to an approximate 
cell contraction of 6.6 Å. This displacement and the broadening of the (110) and (200) 
peaks are related to further condensation of silanol groups during the calcination step. 
Finally, curve c corresponds to the S1 XRD pattern. In this case, a little loss of the (110) 
and (200) reflections is observed, most likely related to a loss of contrast due to the 
filling of the pore voids 
with the rhodamine B 
dye. Nevertheless, the 
value and intensity of the 
(100) peak in this pattern 
strongly evidences that 
the loading process with 
the dye and the further 
functionalization with 
APTS have not damaged 
the mesoporous 3D 
MCM-41 scaffolding. 
The presence in the final functionalized solids of the mesoporous structure is also 
confirmed from the TEM analysis, in which the typical channels of the MCM-41 matrix 
are visualized as alternate black and white stripes (see Figure S2 for MCM-41 calcined 
and solid S1). The figure also shows that the prepared MCM-41 and solid S1 are 























Figure S2. Left: powder X-ray patterns of the solids (a) MCM-41 as synthesized (b) 
calcined MCM-41 and (c) solid S1 containing the dye rhodamine B and 3-
aminopropiltriethoxysilane. Right: TEM images of (a) calcined MCM-41 sample and 
(b) solid S1 showing the typical hexagonal porosity of the MCM-41 mesoporous matrix. 
The N2 adsorption-desorption isotherms of the nanoparticulated MCM-41 calcined 
material shows two sharp adsorption steps. The isotherm shows a first step at 
intermediate P/P0 value (0.1-0.3) typical of these solids (see Figure S3, curve a). This 
step can be related to the nitrogen condensation inside the mesopores by capillarity. The 
absence of a hysteresis loop in this interval and the narrow BJH pore distribution 
suggests the existence of uniform cylindrical mesopores with pore volume of 0.84 cm3 
g-1 calculated by using the BJH model on the adsorption branch of the isotherm. The 
application of the BET model resulted in a value for the total specific surface of 1066.8 
m2 g-1. From the XRD, porosimetry and TEM studies, the a0 cell parameter (43.16 Å), 
the pore diameter (2.57 nm) and a value for the wall thickness (1.74 nm) were 
calculated. In addition to this adsorption step associated to the micelle generated 
mesopores, a second feature appears in the isotherm at a high relative pressure (P/P0 > 
0.8). This adsorption correspond to the filling of the large voids among the particles and 
present a volume of 0.47 cm3 g-1 (calculated by using the BJH model) and then must be 
considered as a textural-like porosity. In this case, the curves show a characteristic H1 
hysteresis loop and a wide pore size distribution.  













































Figure S3. Nitrogen adsorption-desorption isotherms for (a) MCM-41 mesoporous 
material and (b) S1 material. Inset: Pore size distribution of MCM-41 mesoporous 
material. 
The N2 adsorption-desorption isotherm of S1 is typical of mesoporous systems with 
filled mesopores (see Figure 7, curve b), and a significant decrease in the N2 volume 
adsorbed and surface area (0.06 cm3 g-1 and 77.1 m2 g-1 respectively) is observed. The 
most relevant feature is the absence of a sharp step at low-medium relative pressure (0.1 
< P/P0 < 0.4). In fact, this solid shows flat curves when compared (at the same scale) to 
those of the MCM-41 parent material, this indicates a significant pore blocking and the 
subsequent absence of appreciable mesoporosity. Additionally, a certain textural 
porosity is preserved. BET specific surface values, pore volumes, and pore sizes 
calculated from the N2 adsorption-desorption isotherms for MCM-41 and S1 are listed 






Table S2. BET specific surface values, pore volumes and pore sizes calculated from the 
N2 adsorption-desorption isotherms for selected materials. 
 SBET 
(m2 g–1) 
Pore Volume a 
(cm3 g–1) 
Pore size a 
(nm) 
MCM-41 1066.8 0.84 2.57 
S1 77.1 0.06 - 
a Volume (V) and diameter (D) of mesopore. 
 
The content of APTS and rhodamine B in the prepared solids S1 and S1-TBAwere 
determined by elemental analysis, thermogravimetric and delivery studies. The content 
of dye in solid S1-TBAwas determined from the rhodamine B released during the 
capping process of S1 with TBA, by measuring the absorbance of the released dye 
during the washing process. Values of content are detailed in Table S3. The thermal 
analysis of the S1 shows typical behaviour in functionalised mesoporous materials; i.e. 
a first weight loss between 25 and 150ºC related to the solvent evolution, a second step, 
between 150 and 800 ºC due to the combustion of the organics and a final loss in the 
800 - 1000 ºC range related to the condensation of the silanol groups. In addition, from 
elemental analysis of C, H, N, S it is possible to determine the amount 3-
aminopropyltriethoxysilane and rhodamine B contained in the materials calculated in 
millimole per gram of S1 (mmol g–1 S1) using equation 1: 
 
 
where ΔWi% (i = C, N, S) are the weight percentages of carbon, nitrogen or sulphur, Mi 
is the corresponding atomic weight and n is the number of the corresponding atom type 
in one molecule. In addition, the content of dye in solid S1-TBA was determined from 
the dye content in S1 after interaction with TBA aptamer, and determining the amount 
of dye delivered when washing the solids. Also, the amount of dye delivered from S1-
TBA in the presence of thrombin was determined by using values of intensity of the 
fluorescence bearing in mind that, at low concentrations, relation between concentration 
and intensity are linear. Values of content are detailed in Table S3. 




(mmol / g S1) 
αRhodamine B 
(mmol / g S1) 
αTBA 
(mmol / g S1) 
S1 1.65 0.092 - 
S1-TBA 1.65 0.057 0.0164 
 
Taking into account the different amounts of APTS and aptamer TBA in solid S1-
TBA it is possible to estimate the distribution of aptamer onto surface. Using these 
values, we can estimate that S1-TBA material contains 9.87 x 1018 oligonucleotide 
molecules/g solid. Additionally, considering surface value of S1 calculated from N2 
adsorption measurements (77.1 m2/g) and the aptamer content calculated previously, the 
average surface coverage on solid S1-TBA by aptamer molecules is 0.36 molecules/nm2. 
This aptamer surface coverage resulted in an average distance between aptamer 
molecules of about 2.8 nm. On the other hand, and bearing in mind again a typical value 
of external surface of S1 (77.1  m2/g) and the content of APTS (in mmol/g SiO2) 
calculated with elemental analysis and thermogravimetric studies, the average surface 
coverage on solid S1-TBA by APTS molecules is 12.8 molecules/nm2. Finally, using 
the aptamer and APTS contents calculated previously a ratio of 100 APTS 
molecules/aptamer molecule was estimated. 
 
In vitro characterization of S1-TBA in human serum 
The delivery experiments of S1-TBA in human blood plasma showed faster response 
than the response observed in simulated human blood plasma (related with stronger 
ionic strength), showing a tolerance of the system using 10% of human serum. 
Calibration curve for thrombin containing 10 % of human serum was obtained(Figure 
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 Figure S4. Release of rhodamine B from solid S1-TBA in function of the concentration 
of human α thrombin in PBS containing 10% of human serum – from human male AB 
plasma.  
Determination of thrombin in human serum 







75 68.35 ± 5.56 91 
150 147.32 ±  4.08 98 
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